Summary.-In the present study the tube LAI assay was used to monitor the isolation of the TSA of 4 different types of human cancers. Each tumour antigen was found to be specific for tumours arising in the organ from which the TSA was initially derived and which were histopathologically similar. Immunochemical studies revealed that these molecules co-isolate with normal human HLA antigens and are associated with fl2m. On Sephadex G-150, the majority of the papain-solubilized tumour antigen eluted in the mol. wt range 70,000-150,000. Analysis of this material by SDS-PAGE and 6M guanidine-HCl column chromatography indicated that the material is composed of smaller subunits with prominent peaks at 40,000, 25,000 and 12,000 mol. wt. Immunoadsorbent affinity chromatography of the solubilized tumour-membrane constituents on AH-Sepharose-linked horse anti-human-fl2m indicated that the tumour antigens, like HLA molecules, contain a /32m subunit. The specificity of binding of TSA to the immunoadsorbent columns and the immunologically specific abrogation of LAI reactivity were clearly shown. The present study, therefore, indicates that by the isolation of fl2m, human tumour antigens can also be Isolated, since human tumour antigens are associated with fl2m. Whether human TSAs may perhaps be modified histocompatibility antigens remains to be answered. Although the change upon malignant transformation in the pattern of the cell-surface proteins expressing the TSA determinant remains obscure, it would appear that for tumours arising within a given organ, a consistent alteration of cell-surface proteins occurs.
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THE existence of individually unique tumour-specific transplantation antigens (TSTA) in the membranes of chemicallyinduced tumours of experimental animals has been unequivocally demonstrated by both in vivo and by in vitro tests (Baldwin and Barker, 1967; Old and Boyse, 1964) . TSTAs solubilized from tumour cell membranes, either by limited papain digestion or by hypertonic salt extraction from any one tumour, have been heterogeneous (Baldwin and Glaves, 1972; Holmes, Kahan and Morton, 1970) . purified papain-soluble tumour-specific antigen (TSA) from a chemically-induced rodent tumour, by affinity chromatography with syngeneic antiserum directed against the tumour, and showed by reduction and alkylation studies that the TSTAs were composed of component polypeptide chains similar in size to rodent histocompatibility antigens . In addition, studies in other murine and rodent tumour systems suggested that TSTAs from these tumours also bear immunochemical and structural similarities to normal histocompatibility antigens (Bowen and Baldwin, 1975; Comoglio, Bestini and Forni, 1975; Gooding and Edidin, 1974; Invernizzi and Parmiani, 1975; Ostberg et al., 1975) .
In human tumours, the demonstration of a host response to the tumour has depended, in large part, on in vitro assays of antitumour responses against putative tumour-antigens. Halliday and Miller (1972) discovered the phenomenon of tumour-antigen-induced inhibition of leucocyte adherence to glass. This leucocyte adherence inhibition (LAI) assay is based on the findings that nonsensitized leucocytes from both cancer patients and control subjects adhere to glass, whereas leucocytes from cancer patients, but not from control subjects, when mixed in vitro with extracts of tumours arising in the same organ and of the same histological type, undergo a loss of their normal adherence to glass surfaces (Halliday et at., 1975) . Holan et al. (1974) described a modified LAI assay in a rat model that was performed in glass test tubes. In our laboratory, we successfully adapted and modified the glass test-tube assay (tube LAI assay) and it was shown to be a reliable, reproducible qualitative assay for the detection of tumour antigen or of specific antitumour immunity in patients suffering from either breast cancer or malignant melanoma (Flores et al., 1977; Grosser and Thomson, 1975; Grosser and Thomson, 1976; Marti, Grosser and Thomson, 1976; Thomson et al., 1976; Lopez and Thomson, 1977) . Comparable results in these and other tumour systems have been found by other investigators (Powell et al., 1975; Rutherford et al., 1977; Leveson et al., 1977; Fujisawa, Waldman, and Yonemato, 1977) .
In the present study, the tube LAI technique was used to monitor the isolation of the putative tumour antigen from 4 histologically distinct human tumour types. These tumour-cell constituents were compared with each other for their structural and immunochemical similarities as well as for their immunochemical and structural relationships to normal HLA antigens with which they were coisolated.
MATERIALS AND METHODS

Tumour tissues
Malignant melanoma, breast and colon adenocarcinoma and hepatoma tissues from either surgery or necropsy were stored at -40°C until processed. Initially, surgical tumour-tissue specimens were used for the preparation of both phosphate-buffered saline (PBS, pH 7. 3) tumour extracts, and for the isolation of the putative tumour antigens. Subsequently, tumour tissue from necropsy specimens became the principal source of material for isolation of tumour antigens, since large quantities of tumour were needed to isolate sufficient quantities of the required material. The tumour tissue from necropsy and surgical specimens had comparable activity in the tube LAI assay.
Tube leucocyte adherence inhibition assay (tube LAI assay) The tube LAI assay was performed and the results computed as previously described (Flores et al., 1977; Thomson, 1975; . Based upon studies of a large number of patients with breast cancer, malignant melanoma, and control subjects with unrelated neoplastic disease or non-cancerous diseases, a Nonadherence Index (NAI*) of 30 or more has been established as a positive LAI test with either PBS-extracted tumours or papainsolubilized tumour-antigen preparations (Flores et al., 1977; ; . The protein content of samples was measured by the procedure of Lowry et al. (1951) with bovine serum albumin as a standard.
"Blocking" tube LAI assay
The blocking tube LAI was performed as previously described (Grosser and Thomson, 1978) . The isolated antigen was diluted with 5% foetal calf serum (FCS) in Medium 199 and 0 5 ml of this solution was added to 1-3 x 107 peripheral blood leucocytes (PBL) suspended in 0 5 ml of Tumour-tissue membranes were prepared as previously described Thomson et al., 1976) . The purified membranes were digested with 0 5 units papain/mg of membrane protein and the papain-solubilized material was isolated by sequential DEAE Sephadex A-50 and Sephadex G-150 chromatography (87 x 5 cm) as previously described . The presence of tumour antigenic activity in the isolated fractions were monitored by tube LAI. Physiochemical and immunochemical characterization of isolated papain-solubilized tumour membrane material
The isolated papain-solubilized material was labelled with 1251 by the chloramine-T method of Greenwood, Hunter and Glover (1963) . Molecular weight and subunit structure were estimated by Sephadex G-200 chromatography in guanidine HCI and sodium duodecyl sulphate: polyacrylamide-gel electrophoresis (SDS-PAGE).
Guanidine-HCl chromatography.-The 1251-labelled papain-solubilized membrane material was adjusted to 6 M guanidine-HCl, reduced with 0-1 M dithiothreitol for 6 h at 370C, and subsequently chromatographed by ascending flow on a Sephadex G-200 column (95 x 1-5 cm) equilibrated with 6 M guanidine-HC1. The column had been previously calibrated with protein standards that had been reduced in an identical fashion. SDS-PAGE.-The 125I-labelled papainsolubilized membrane preparations were electrophoresed on 10% SDS-tube gels by the method of Weber and Osborn (1969) or by the discontinuous method of Laemmli (1970) in 12.5% SDS gels. The gels were then cut into 1-5 mm-thick slices that were counted individually in a y-spectrometer. The protein standards, bovine serum albumin (67,000 mol. wt), aldolase (40,000 mol. wt), pepsin (35,000 mol. wt), chymotrypsinogen (25,000 mol. wt) and cytochrome C (12,400 mol. wt) were always run simultaneously on a parallel gel to calculate the apparent molecular weights of the radio-labelled peaks. Unlabelled material along with protein mol. wt standards was also run in high resolution SDS slab gels (0.75 mm thick) by the discontinuous method of Laemmli (1970) Poulik) was prepared by immunization of horses. The antiserum did not react with normal human serum. By radioimmunoelectrophoresis, the antiserum gave a single band with the low-mol.-wt fraction of serum or urine rich in J32m. In addition, the antiserum was absorbed with normal human serum coupled to Sepharose beads, to avoid any possible reaction with human immunoglobulins that may not be detected by precipitation reactions in agar gel. The antiserum for affinity chromatography was selected for its low titre to make possible more efficient elution from the affinity column.
An antiserum recognizing a common antigenic site on the heavy chain of the HLA molecule was prepared as described by Cresswell and Ayres (1976) . The papain-soluble HLA antigen was prepared from isolated normal-liver cell membranes. The material that eluted from a Sephadex G-150 column in the mol. wt range -45,000 was then isolated by horse anti-human-fl2m immunoabsorbent affinity chromatography. The bound fraction that was eluted from the affinity column was enriched for fl2m and the isolate was rechromatographed on a Sephadex G-100 column. The fraction eluting in the mol. wt range -45,000 was used to immunize rabbits. Antibodies to the fl2m subunit of Antisera to non-fl2m cell-surface proteins were raised in rabbits to papain-soluble breast cancer and melanoma membrane material that had not bound to the horse anti-fl2m affinity column. The IgG derived from the antisera was used unabsorbed in affinity chromatography after coupling to AH-Sepharose 4B. The antiserum raised in rabbits to normal human serum (NHS) was absorbed before use on an affinity column of papain-soluble liver-cell membranes linked to AH-Sepharose 4B.
Chromatography of the TSA on an antihuman-/2m immunoadsorbent affinity column.-A horse anti-human-32m affinitychromatography column was prepared as previously described .
A column (35 x 2-5 cm) was packed with 170 ml AH-Sepharose 4B coupled to 4-5 g of horse y-globulin isolated from specific anti-human-32m serum by DEAE chromatography. The fraction from the Sephadex G-150 column with tumour antigen, as determined by tube LAI assay, or similarly prepared control material, was applied to the anti-92m immunoadsorbent affinity column in PBS. After the unbound fraction had been washed through with 10 column-volumes of PBS the columns were prewashed with 1-0 m NaCl, NaOH-glycine buffer, pH 9 0, to remove nonspecifically absorbed proteins (Zoller and Matzku, 1976) . The specifically bound material was then eluted with 3 0 M KSCN. All procedures were performed at 4°C. The bound fraction was immediately dialysed against PBS at 4°C and, after overnight dialysis, the dialysed residue was centrifuged at 75,000 g for 1 h and concentrated by ultrafiltration. The unbound fraction was treated in an identical manner.
The 32m content in all the fractions was measured by radioimmunoassay . A double antibody radioimmunoassay for HLA was used to detect HLA as described by Cressw-ell and Ayres (1976) .
Specificity of anti-human-J32M immunoadsorbent column. Specificity of the horse anti-human-182m immunoadsorbent affinity column was shown as follows: albumin did not bind to the anti-fl2m affinity column and was quantitatively recovered in the effluent. When the immunoadsorbent was initially reacted with fl2m and washed, and then human serum albumin was passed through the column, no 92m was detectable in the albumin wash by f2m radioimmunoassay, although all of the albumin was recovered. If the anti-J32m immunoadsorbent column was overloaded with ,2m and washed, and then ,2M was again applied to the column, the quantity of the ,2m recovered in the effluent was equal to that applied. Hence, the P2m binding showed marked specificity.
Prewashes of the affinity columns to remove nonspecifically absorbed proteins with 1-0 M NaCl, NaOH-glycine buffer, pH 9 0, failed to remove any 32m activity in the prewash, and the tumour antigen remained bound to the affinity column (Zoller and Matzku, 1976) . To demonstrate further the specificity of 32m
binding, immunoadsorbent columns of normal lgG from both humans and rabbits were prepared by covalently coupling the materials to AH-Sepharose 4B. In 1975 , Reisfeld et al. (1975 reported that the specificity of absorption of HLA antigen to anti-J32m antibody sites by immunoadsorbent affinity chromatography is acceptably demonstrated by initially reacting the immunoadsorbent with an excess of f2m, thoroughly washing the column, then incubating with HLA antigen for 4 h and showing that no HLA antigen exchanges for the bound /2m. Conversely, however, Robb, Strominger and Mann (1976) showed more recently that f2m displaced HLA on an anti-/2m affinity column, and the columns were easily regenerated by acidic washes. In the experiments reported here, studies were performed with 3 different affinity columns under the same conditions described by Reisfeld et al. (1975) to determine whether specificity of binding could be shown by the method they had described. With the anti-32m affinity column, 48% of 1251-/32m exchanged for bound and unlabelled fl2m at the end of 4 h incubation at 4°C. With a rabbit anti-rat-yG affinity column, 47 0 of rat 1251-yG exchanged with bound and unlabelled yG. Finally, with an anti-CEA affinity column, 610 of 1251-CEA exchanged with bound and unlabelled CEA. By these experiments with 3 different affinity columns, we were unable to repeat the observations of Reisfeld et al. (1975) and we miust conclude that the criteria described by that group for the demonstration of immunoadsorbent specificity are certainly not universally applicable.
RESULTS
Each tumour used for isolation of TSA was tested as a PBS extract in the tube LAI assay against PBL from an appropriately reactive cancer patient and a normal control subject. Fig. 1 shows the number of non-adherent leucocytes from a breast-cancer patient and a control subject when incubated with various concentrations of a PBS extract of either breast cancer or hepatoma. At protein concentrations of 100 to 150 ,ug/tube, the leucocytes from the breast-cancer patient showed a significantly greater degree of nonadherence in the presence of the breastcancer extract than of the hepatoma extract. In contrast, the leucocytes from the control subject showed almost equal degrees of nonadherence in the presence of the tumour extracts at all protein concentrations ( Fig. 1) . The breast-cancer patient had a positive NAI, whereas the control subject had a negative NAI. Identical results for the leucocytes from patients with malignant melanoma and hepatoma, with their corresponding tumour extracts and appropriate controls, were noted ( Fig.  1 ). Fig. 1 shows that the optimum tumourdirected LAI response (NAI value) is observed at 100 ,ug protein/tube, and as previously observed (Flores et al., 1977; Thomson, 1975, 1976; does not have a quantifiable dose-response.
Chromatographic isolation of papain-solubilized membrane tumour antigens
In previous studies, the,,PBS extract of breast cancer was chromatographed on Sepharose 4B and the antigenic activity was shown to be present in the void volume (Grosser and Thomson, 1975) . When purified tumour membranes from breast cancer and melanoma were used as antigen in the tube LAI assay, it was shown that the leucocytes from patients with breast cancer and melanoma had LAI reactivity to the tumour membranes of the corresponding histopathological type of tumour . In the present study, when the isolated tumour membranes were digested with papain to yield a water-soluble tumourantigen preparation, andthepapain-soluble membrane material was chromatographed on DEAE-Sephadex A-50 as an initial step to remove highly charged materials, especially DNA, tumour antigenic activity was found in the unbound fraction and not in the bound fraction (data not shown). Up to 60% of the protein was lost in this step (Table XI) . The unbound fraction of the papain-soluble breast-tumour material was chromatographed on Sephadex G-150, and Fig. 2 shows the 4 fractions that were pooled for assay by tube LAI. The fractions corresponded roughly to the void volume (Fraction 1), the elution volume of aldolase (Fraction 2), the elution volume of ovalbumin (Fraction 3) and the elution volume ofribonuclease (Fraction 4). In the melanoma preparations, the LAI activity was present principally in Fractions 1 and 2 (Table I ). The tumour antigen or LAI activity of papain-soluble membrane from breast cancer was also found principally in Fractions 1 and 2 (Table II) . Such activity was occasionally found in Fraction 3 although the activity recovered was generally less than that found in either of Fractions 1 or 2. Fig. 2 shows that Fraction 2 represents material that elutes o. in the mol. wt range 70,000-150,000, whereas Fraction 3 includes material eluting in the mol. wt range 30,000-70,000. Material with mol. wt <30,000, found in Fraction 4, infrequently showed LAI activity. Thus, the results indicate that the papain-solubilized tumour-membrane fractions that showed tumour-antigen activity in the standard tube LAI assay eluted principally in the mol. wt range 70,000-150,000 or >150,000 (Tables I  and II ).
In the tube LAI assay, PBS extracts are used as the standard antigen; hence, in the initial experiments the papainsolubilized material from the cancer-cell membranes were used as the specific antigen, and compared with the PBS cancer extracts as the nonspecific antigens. Tables I and II Subsequently, the differences in leucocyte reactivity to the specific and nonspecific antigens was compared when both antigenic materials were papain-solubilized extracts of the cancer-cell membranes isolated in an identical fashion (Tables I  and II LAI assay (Thomson, 1978) . To solve this problem, we have recently used the blocking tube LAI assay to detect the presence of TSA activity (Lopez and Thomson, 1977; Thomson, 1978) . Fig. 3 shows the 1251 profile on 10% SDS-gels of papain-soluble breast cancer and melanoma material from Fraction 2 of the Sephadex G-150 column. Two major radioactive peaks with mol. wt of 12,000 and 40,000, and a relatively minor peak with mol. wt /25,000 were observed. Similar gel patterns were observed whether or not the gels were run in the presence or absence of the reducing agent mercaptoethanol.
Guanidine-HOl chromatography of papainsoluble tumo ar-antigen material
The 1251-labelled papain-soluble breastcancer material from Fraction 2 of the Sephadex CG-150 column, composed of material of mol. wt 60,000-150,000, was chromatographed on Sephadex G-200 in 6 M guanidine-HCl and found to consist of smaller subunits (Fig. 4) . Moreover, smaller subunits were observed when chromatography was carried out in the presence or absence of dithiothreitol (Fig. 4) . Fraction 2 from the Sephadex G-150 column obtained from the papainsolubilized melanoma material, similarly chromatographed, resolved into smaller mol. wt subunits (Fig. 4) The bound and unbound fractions were tested against leucocytes from both specifically LAI reactive patients and control subjects. Table IV shows the LAI response of melanoma patients and control subjects to the unbound and bound melanoma fractions from the anti-32m affinity column. The leucocytes from the melanoma patient showed positive LAI reactivity to the bound melanoma fraction containing 82m, contrasting with the negative reaction of the control subject. Moreover, the leucocytes of the reactive melanoma patient showed no LAI reactivity to the Q_ 0. unbound, /32m free, fraction. Identical results were observed when leucocytes from reactive breast-cancer patients and control subjects were tested against unbound and bound papain-soluble breastcancer fractions from the anti-32m affinity column (Table V) . Those fractions that contained /32m and specifically reacted in the tube LAI assay also contained HLA antigens, as determined by radioimmunoassay.
Initially, the leucocyte reactivity to the papain-solubilized membrane material from cancers isolated by anti-32m affinity chromatography was compared to a nonspecific PBS tumour extract, and Tables IV and V show that the antigens isolated from the anti-/32m affinity columns can replace their equivalent PBS tumour extract and retain specific antigen activity. Next, papain-soluble material from hepatoma membranes was isolated by anti-/2m affinity chromatography, and this material, rather than PBS tumour extracts, was used as the control antigen in the tube LAI assay (Table VI) . The leucocytes from the reactive melanoma patient showed LAI activity against the bound melanoma fraction from the antif2m affinity column (Table VI) . Likewise, leucocytes of reactive breast patients displayed LAI activity to the bound breast-cancer fraction from the anti-/2m affinity column. Leucocytes from the melanoma and breast-cancer patients showed no reactivity to the corresponding unbound fractions. By contrast, leucocytes of the control subjects showed no LAI activity either to the bound or to the unbound fractions.
A reactive hepatoma patient and a control subject were tested against the unbound and bound hepatoma and breast fractions from the anti-/32m immunoadsorbent affinity column (Table VII) . was re-applied to the anti-2m immunoadsorbent affinity column and the unbound and bound fractions were retested against the leucocytes from the reactive hepatoma patient and the control subject. After this recycling leucocytes from the hepatoma patient had LAI reactivity only to the bound fraction containing fl2m and not to the unbound fraction that was now free of P22m. Leucocytes from the control subject showed no LAI reactivity.
To determine if the papain-soluble cancer antigens bound specifically to the anti-f2m immunoadsorbent column, papain-soluble breast-cancer material was applied to immunoadsorbent columns of normal IgG from both humans and rabbits. About 85% of the material applied to the columns remained in the unbound fraction, and #7 7% of the material applied was recovered in the bound fraction by elution with 3 M KSCN. The unbound material retained the antigenic activity when assayed by tube LAI, whereas the bound fraction had no activity (Table IX) . In addition, by f2m radioimmunoassay no f2m was in the bound fraction, whereas the unbound fraction had f2m activity (Table IX) .
In the preceding studies (Tables IV, V breast-cancer patients were tested against 4 breast-cancer preparations with identical results. Similarly, leucocytes from 3 different melanoma patients and 2 colon-cancer patients were tested against 2 melanoma and 2 colon-cancer preparations with identical results. Moreover, the reactivity of leucocytes to the specific tumour material that bound to the anti-32m affinity column and the tumour material which did not bind was highly significant (P< 0*001).
In addition, the binding of the TSA to the anti-32m affinity column was specific, since the TSA did not bind to control affinity columns (Table X) . Passage of the bound material from the anti-32m column through an anti-NHS column did not remove the blocking activity, indicating that the antigen had bound specifically to 764 --I the anti-/32m column (Table X) . Similarly, papain-soluble breast material from Sephadex G-150 Fraction 2 was passaged through an affinity column of normal rabbit IgG and the antigen activity was found in the unbound fraction, indicating again that binding to the anti-32m column was specific (Table X) .
Also, antisera to non-f32m cell-surface proteins were raised in rabbits to papain- t The bound papain-soluble breast-cancer material from the anti-human-fl2m affinity column was passaged through an anti-NHS affinity column and the unbound and bound material was tested for blocking.
soluble breast-cancer and melanoma membrane material that had not bound to the horse anti-/32m affinity column. The IgG (unabsorbed) derived from these antisera was linked to AH-Sepharose 4B, along with antiserum to NHS that had been absorbed on papain-soluble liver-cell membranes linked to AH-Sepharose 4B. On this column, which had only recently been prepared, the papain-solubilized TSA of bowel cancer in Sephadex G-150 Fraction 2 material was shown not to bind, indicating that antisera prepared to cell-surface proteins excluding f2m and /32m-linked proteins does not bind the colon TSA (Table X) . The passage of papain-solubilized tumour membrane from Fraction 2 through the horse anti-/2m affinity column completely deleted from the material its LAI activity, associated with a proportionate loss of the weight of the starting material. A variable loss of antigenic activity occurred during the brief exposure to the 3M KSCN, due to denaturation. Also, the results in Tables VIII and XI indicate that recovery of the material applied to the anti-human-32m affinity column was not complete. The loss was variable and ranged between 20 and 40%. Typical yields of materials from each step during the isolation of the papain-solubilized TSA are shown in Table XI . The yields were fairly consistent on each occasion.
In fractions with no 32m, no LAI activity was found. On the other hand, free /32m from urine or normal liver tissue showed no activity in the tube LAI assay. Hence. the antigen that is reactive in the LAI is a molecule that is associated with /2m but is not fl2m itself. 2m was present in all fractions from the Sephadex G-150 column, and the quantity increased in the lower mol. wt fractions (Fig. 3) . Although Fraction 2 does not have large quantities of f2m, the tumour-antigen activity eluted principally in this mol. wt fraction and was associated with 2m. SDS-PAGE of material isolated by the anti-f2mn affinity column Fig. 5 shows the' 10%-SDS-gel electrophoresis profile of 1251-labelled material from the bound fraction of the anti-/32m affinity column. Breast cancer, melanoma and hepatoma material appear to be composed of 2 major subunits with mol. wts of ,12,000 and 40,000. A minor peak was observed at~25,000. Although the hepatoma material showed a major peak between 40,000 to 35,000, it was diffuse and appeared more heterogeneous with more or less distinct peaks with mol. wts of 35,000, 40,000 and 50,000. Also, the major peak at -40,000 from the melanoma and breast material showed heterogeneity. The small irregularities observed in the contour of the peak were seen in the same preparation run on separate occasions, and in different preparations prepared in a similar manner. To be certain that the materials isolated from the anti-/2m affinity column were not substances that had "bled" from the column, and were subsequently labelled with 125J, antigenic material to be applied to the affinity column was prelabelled and the 1251 profiles of'the material applied, unbound and bound, were then analysed by 10% SDS-PAGE. Fig. 6 shows the 125I profiles. The material bound to the column has a similar profile to that when the material was labelled after elution from the affinity column. This indicates that contamination by "bleeding" from the column co determine the pattern on staining with cancer material bound and eluted from an Coomassie blue. Fig. 7 shows the Coomas-immunoadsorbent column of normal rabbit sie-blue SDS-PAGE profile of papain-IgG. Since only small quantities of the soluble breast-cancer material isolated papain-soluble material adhered to the from the horse anti-human-32m immuno-control column, it was necessary to conadsorbent affinity column. Slot 7 shows centrate the material in contrast to that the pattern of papain-soluble breast-of the material bound and eluted from the FIG. 7.-Coomassie blue stain of isolated papain-soluble breast-cancer material after PAGE on slab gel with a 5-20% gradient of polyacrylamide. Slots 3, 4 and 8 show the protein standards (from top to bottom): phosphorylase (90,000); albumin (68,000); ovalbumin (43,000)); chymotrypsinogen (25,000); and cytochrome C (12,400). Slot 7: papain-soluble breast-cancer material (Fraction 2) bound and eluted from an immunoadsorbent column of normal IgG. Slot 1: a preparation of papainsoluble breast-cancer material bound and eluted from an immunoadsorbent horse anti-human-fl2m.
Slot 2: the same preparation as applied to Slot 1 except the material had been passed through an immunoadsorbent column of rabbit anti-human-whole-serum. Slots 5 and 6: another preparation of papain-soluble breast cancer material bound and eluted from an immunoadsorbent column of horse anti-human-,2m. The gel was overloaded to detect minor contaminants and slot 6 had twice as much protein as Slot 5. The papain-soluble breast-cancer material shown in Slots 1, 2, 5 and 6 had TSA activity in the tube LAI assay, whereas the material in Slot 7 had no LAI activity.
horse anti-32m immunoadsorbent affinity column (Slots 1, 2, 5, 6 Autoradiography of the material in Slot 2 revealed intense bands at 12,000, 26,000, and 40,000 mol. wt, with the bands at 12,000 and 26,000 being stronger than the 40,000 band; other bands were also seen though they were much fainter (Fig. 8) . The material electrophoresed in Slot 2, after passage through the rabbit anti-human-normal-serum affinity column, retained its antigen activity in the tube LAI assay (Table X) . The breast TSA isolated from the immunoadsorbent column of horse anti-human-/2m that gave the patterns seen in Slots 1, 2, 5 and 6 (Fig. 7) had specific LAI activity when assayed by the standard and blocking tube LAI and contained /2m and HLA xenoantigenic activity by radioimmunoassay.
The papain-soluble colon-cancer material isolated by anti-32m affinity chromatography when electrophoresed on the highresolution SDS slab gels and stained with Coomassie blue showed bands at -.12,000, 25,000, 40,000 and 50,000 mol. wt. The band at 50,000 and a portion of the material at 25,000 mol. wt probably represent the H and L chains of IgG that bled from the column during elution with 3M KSCN. A faint band was also observed at -65,000 mol. wt. The unbound and bound papain-soluble colonic-cancer material from the anti-non-/2m affinity column were run on the high-resolution SDS slab gel and stained with Coomassie blue. In this instance, the unbound colon material showed intense bands at -.12,000, 25,000, and 40,000 mol. wt, whereas the pattern of the bound material was entirely different and lacked these 3 prominent bands.
Xenoantiserum raised to the papainsoluble Br.Ca.Ag. and absorbed withnormal human serum bound 125J-/2m-Br.Ca.Ag. and 1251-HLA but not 1251-/2m (Table  XII) with an excess of the xenoantiserum to either HLA or 32m-Br.Ca.Ag., no additional material could be subsequently immunoprecipitated with the other xenoantiserum. This indicated that both xenoantiserum recognized similar xenoantigenic determinants on the heavy chain of HLA. Next, 1251-fl2m-Br.Ca.Ag. was reacted with xenogeneic anti-human 32m, anti-HLA, anti-32m-Br.Ca.Ag. and normal rabbit serum, and then Staphylococcus aureus Cowan 1 was used as a bacterial adsorbent, as described by Kessler (1975) . The adsorbed immune complexes were released by boiling for 2 min in 2% SDS buffer and 2% mercaptoethanol, and the freed immune complexes were run in SDS gels by the discontinuous method of Laemmli (1970) . Similar peaks of radioactivity were observed at '-.40,000, 25,000, 12,000 mol. wt with immune complexes produced by the xenoantisera to /2m, HLA and /32m-Br.Ca.Ag. Normal rabbit serum gave no radiolabelled peaks.
DISCUSSION
In the present study, the standard and blocking tube LAI assays were used to monitor the isolation of tumour antigen of 4 different types of human cancer. The tumour antigen, solubilized from the tumour cell membranes by papain, was isolated by techniques routinely used for purification of human HLA antigens (Peterson, Rask and Lindblom, 1974) . Immunochemical studies revealed that the tumour antigen molecules co-isolated with material indistinguishable physicochemically from HLA antigens, which undoubtedly represented the major constituents in the materials isolated. The TSAs bore a distinct similarity to normal human HLA antigens in their linkage to P2m (Peterson et al., 1974) . In the present study, when the isolated papain-soluble TSA and reactive leucocytes were from patients with cancers of similar origin and histology, the papainsoluble TSA was able to inhibit the glass adherence of the leucocytes to a greater extent than papain-soluble TSA or PBS tumour extracts from an unrelated tumour. However, the standard tube LAI assay performed in serum-free medium is highly dependent on protein concentration (Grosser and Thomson, 1975; Flores et al., 1977; Lopez and Thomson, 1977; Thomson, 1978) and titration of the isolated papain-soluble antigens below 50 ,ug becomes unreliable because the number of nonadherent cells is too few to be counted with any consistency. Hence, a blocking tube LAI assay Lopez and Thomson, 1977; Thomson, 1978) was used to quantitate the TSA activity in the isolates. The advantages of the blocking tube LAI over the standard tube LAI for the detection of TSA in tumour isolates has recently been discussed (Thoinson, 1978) . Moreover, in the present study, on each occasion care was taken to show that TSA activity detected by either assay was immunologically specific. Although it appeared highly unlikely that the papainsoluble TSAs would absorb quantitatively in a nonspecific fashion to the immunoadsorbent column, this possibility was excluded, since TSA activity was not removed by immunoadsorbent columns of either IgG derived from antisera to non-f2m cell-surface proteins or to NHS or IgG derived from normal human and rabbit serum. Similarly, immunoadsorbent columns used in the isolation of TSA from the serum of patients with metastatic breast cancer were shown not to bind the TSA in a nonspecific manner (Lopez and Thomson, 1977) .
After Sephadex G-150 chromatography, the majority of the soluble TSA was present in the fraction that eluted in the mol.
wt range 70,000-150,000. TSA activity was present in the excluded fraction; however, this fraction was not extensively studied because of the possibility that it could represent, in part, unsedimented membrane fragments rather than watersoluble TSA. TSA activity was detected in other fractions but usually less frequently and with less activity. Possible explanations for some variability in the elution position of the papain-soluble TSA may be related to differences in papain digestion, the extent of aggregation with storage and/or the degree of autolysis of original tumour samples. Hence, in the present study attention was focused on the further isolation and characterization of the material containing TSA activity that eluted in the mol. wt range 70,000-150,000.
Analysis of the material with TSA activity in the 70,000-150,000 mol. wt range by SDS-PAGE and 6M guanidine-HCI column chromatography indicated that the material was composed of smaller subunits. The presence of a prominent band on SDS gels at 12,000 mol. wt suggested that the material contained P2m, and this was confirmed by /2m radioimmunoassay of the whole material. Hence, affinity chromatography with horse anti-human-/2m was undertaken to determine whether the TSAs might be associated with /2m. The results showed that the papain-solubilized TSAs from tumours of 4 different origins and histology bound specifically to the anti-/2m affinity column. Analysis of the bound material from the 4 different tumours by SDS-PAGE consistently showed major peaks at about 12,000, 25,000 and 40,000 mol. wt. Thus, papain-soluble material from the cell membranes of breast and bowel cancers, melanoma and hepatoma isolated by anti-f2m affinity chromatography have similar molecular weights and subunit structures. It is not known, however, whether the chain that carries the TSA epitope is on the 25,000 or 40,000 chains; moreover, it is possible that the chain carrying the TSA epitope is not visualized by the SDS gels.
The studies of Nakamuro, Tanigaki and Pressman (1977) have suggested that 62m is exclusively conmbined with the HLA large component, and no other membrane components are involved in binding /2m. Likewise, Robb et al. (1976) claim that detergent-solubilized HLA antigen is rapidly purified with very little contamination by affinity chromatography with rabbit anti-human-32m. The fact, therefore, that the papain-soluble human TSAs from breast and bowel cancer, melanoma and hepatoma bound specifically to the ant-32m immunoadsorbent suggests that the TSA determinant is possibly an integral part of the HLA molecule or alternatively, is physically associated with the HLA molcule. Moreover, breast TSA isolated from serum and urine also co-isolates with HLA antigens and appears to share the same xenoantigenic determinants as present on the heavy chains of HLA antigens (Lopez and Thomson, 1977) . Obviously, not all the molecules that are noncovalently linked with /2m are TSAs since even if the TSA is eventually proved to be a modified HLA antigen, it is unlikely that all 4 of the individual allogeneic molecules would be altered (Blank and Lilly, 1977) .
Not surprisingly, rabbits immunized with papain-soluble breast-cancer material isolated from the anti-/2m affinity column and containing TSA activity did not result in the rabbit producing a reagent that recognized the TSA determinant. Antisera prepared in rabbits, even to purified HLA antigens, are not likely to produce reagents of great value in revealing HLA allospecificity (Sanderson, 1977) . The rabbit can be expected to differ from man at several places other than the epitope on the HLA chain, so allospecific globulins would comprise a minor portion of the total antibody formed against the whole alloantigen chain with its attendant /32m (Sanderson, 1977) . Similarly, the protein chain in humans that carries the TSA epitope, whatever the origin of the protein, might be expected to differ from rabbit at several sites other than the TSA epitope.
In addition, transplantation antigens solubilized from normal and neoplastic tissues with limited papain digestion demonstrate non-H-2 activity as well as H-2 activity, as indicated by skin-graft rejection (Graff and Nathenson, 1971) . Recent biochemical evidence suggests that the antigenic products of both T/t and H-2 are structurally similar, and t12 has been reported to be associated with a /2m-like moiety in the membrane (Artzt and Bennett, 1975; Michailson et al., 1977) . Similar results have been reported for the TL antigen (Artzt and Bennett, 1975; Michailson et al., 1977; Ostberg et al., 1975 ) which is closely linked to H-2D and apparently has a reciprocal interaction with it in the plasma membrane. In addition, in the region between H-2D and T/a, genes specify for a cell surface molecule Qa-2 which is similar to H-2D in molecular weight and association with /32m (Michailson et al., 1977) . It is suggested that a family of molecules related by size, subunit structure, genetic linkage, membrane location and antigenicity may exist in this area of the chromosome, and may have arisen from a common ancestral gene (Michailson et al., 1977) . Thus, in humans, similar non-HLA antigens may exist and structurally resemble antigens of the HLA complex; and these non-HLA antigens could possibly be involved in the expression of cell-surface TSAs.
Evidence has accumulated, however, to support the concept that HLA antigens represent the markers of self-recognition. The existence of such a mechanism provides a biological basis for the evolution of strong transplantation antigen systems, a known physiological role for which has been lacking. Doherty, Blanden and Zinkernagel (1976) have proposed that the T cell recognizes an "altered self" antigen formed by an interaction between H-2 coded structures at the D and K regions of major histocompatibility complex (MHC) and the "inducing" antigen. To date, the data from studies with haptenated cells (Shearer, Rehn and Garbarino, 1975) , non-H-2 alloantigens (Bevan, 1975) including the sex-linked H-Y antigens (Gordon, Simpson and Samelson, 1975) , viral infected cells (Zinkernagel and Doherty, 1974 ) and a haptenated H-2-deficient tumour line (Forman and Vitetta, 1975) support the altered-self interaction antigen (Bevan, 1975) adaptor-antigen complex (Schrader and Edelman, 1976) hypothesis. Nevertheless, the mechanism by which antigen associates with MHCcoded gene products to form the new altered self or altered antigen is not yet clear. Moreover, the existence of altered self antigens has not been shown biochemically.
Human TSAs could possibly be of 3 different origins:
1. The TSA could be a modified MHCcoded structure;
2. The TSA could be spatially linked with the HLA antigens but on independently coded molecules with the HLA molecules serving as adaptors that combine with anitigens on the cell surface to form hybrid antigens containing elements of self (HLA) and non-self (TSA) (Ohno, 1977; Schrader, Cunningham and Edelman, 1975) . In this context, however, a preliminary examination of our breast-cancer tumoutr isolates for associated murine mammary-tumour viral antigens have given negative results;* 3. TSA could be a molecule that is unrelated to HLA antigens and is expressed * Our anti-fl2m-Br.Ca.Ag. serum does not precipitate any of the MMTV polypeptides, and the radiolabelled fl2m-Br.Ca.Ag. was not precipitable with antisera to MMTV polypeptides. The cold 212m-Br.Ca.Ag. did not inhibit radiolabelled virus in RIA; if putative MMTV antigen was present, the concentration was < 1 ng/50 1l. These studies were kindly performed for us by Dr R. D. Cardiff, Dept. of Pathology, University of California, School of Medicine, Davis, California. separately on the cell surface, but may share some xenoantigenic determinants and/or structural features with the HLA antigens.
The data from our studies are insufficient to determine which, if any, of the above possibilities is correct. Nevertheless, the results of the present study provide a unified approach to the isolation of human TSA from cancers arising in different organs.
